Vycor Medical (VYCO.OB) to Acquire NovaVision and its Vision Restoration Therapy Technology
Medical device manufacturer of next generation neurosurgery retraction devices, Vycor Medical, Inc. announced that it has entered into a purchase agreement to acquire all the assets of NovaVision, Inc., including its German subsidiary, NovaVision AG, and its patented and FDA-approved technologies for non-invasive Vision Restoration Therapy (VRT) for an aggregate price of $900,000. VRT is a clinically-proven, patient-specific diagnostic and therapeutic therapy that has been clinically shown to restore vision loss as a result of neurological trauma from instances such as stroke or brain injury. Also important, it is notable that the NovaVision products have CE marking, a mandatory conformance…